Regencell Bioscience Holdings Ltd stock is traded at $5.58, with a volume of 45,856. It is up +6.69% in the last 24 hours and down -24.08% over the past month. Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
Previous Close:
$5.23
Open:
$5.38
24h Volume:
45,856
Relative Volume:
0.27
Market Cap:
$2.77B
Revenue:
-
Net Income/Loss:
-$7.05M
P/E Ratio:
-
EPS:
-$0.0142
Net Cash Flow:
-$767.30K
1W Performance:
+2.95%
1M Performance:
-24.08%
6M Performance:
-79.58%
1Y Performance:
-61.62%
1-Day Range:
$5.30$5.62
1-Week Range:
$5.05$5.73
52-Week Range:
$4.51$69.00
Regencell Bioscience Holdings Ltd Stock (RGC) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS